We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Germany-based drug delivery systems developer AMW has signed an agreement to be acquired by a consortium led by private equity firm Yunfeng (YF) Capital and Chinese drug developer Hybio Pharmaceutical.